Drug Type Small molecule drug |
Synonyms |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 3 | KR | 19 Apr 2024 | |
Dyslipidemias | Phase 3 | KR | 19 Apr 2024 |